Investor mix
3 investors on record; lead investors include Bio/Med Investor Network.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Angel & family office | 1 | 33% |
Developing therapeutics to restore cellular function in neurodegenerative diseases
3 investors on record; lead investors include Bio/Med Investor Network.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Angel & family office | 1 | 33% |